Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Dissection of a Complex Disease Susceptibility Region Using a Bayesian Stochastic Search Approach to Fine Mapping.
Rituximab combination therapy in relapsing multiple sclerosis.
Neuroimmunology: Cyclosporine A and azathioprine are effective adjunctive treatments for neuromyelitis optica.
Missing links in multiple sclerosis etiology. A working connecting hypothesis.
Direct and indirect cost burden associated with multiple sclerosis relapses: Excess costs of persons with MS and their spouse caregivers.
Social and economic burden of walking and mobility problems in multiple sclerosis.
Disruption of nodal architecture in skin biopsies of patients with demyelinating neuropathies.
Multiple sclerosis: RBPJ identified as an autoantigen in multiple sclerosis.
Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial.
Early netrin-1 expression impairs central nervous system remyelination.
Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods.
Central nervous system myeloid cells as drug targets: current status and translational challenges.
Evaluation of the Acquisition of the Aerobic Metabolic Capacity by Myelin, during its Development.
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01)
Dynamometer-based measure of spasticity confirms limited association between plantarflexor spasticity and walking function in persons with multiple sclerosis.
Loss of Allograft inflammatory factor-1 ameliorates experimental autoimmune encephalomyelitis by limiting encephalitogenic CD4 T cell expansion.
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.
Preferred features of oral treatments and predictors of non-adherence: two web-based choice experiments in multiple sclerosis patients.
Laminar cortical damage in multiple sclerosis.
Unmet care needs of people with a neurological chronic disease: a cross-sectional study in Italy on Multiple Sclerosis.
Reduced Retinal Nerve Fiber Layer Thickness and Macular Volume in Pediatric Multiple Sclerosis.
The effect of ribavirin on reactive astrogliosis in experimental autoimmune encephalomyelitis.
Do Bugs Control Our Fate? The Influence of the Microbiome on Autoimmunity.
Evaluation of Inner Retinal Layers in Patients with Multiple Sclerosis or Neuromyelitis Optica Using Optical Coherence Tomography.
Usability and Potential of Geostatistics for Spatial Discrimination of Multiple Sclerosis Lesion Patterns.
Pages
« first
‹ previous
…
322
323
324
325
326
327
328
329
330
…
next ›
last »